Publications by authors named "Brooke Daniel"

Claim this Profile
A
Advancing the Care of Women With HER2-Positive Metastatic Breast Cancer.
Marcie Beasley, Brooke Daniel

J Adv Pract Oncol· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Insights into the Spectrum of Activity and Mechanism of Action of MGB-BP-3.
Charlotte Hind, Melanie Clifford, Charlotte Woolley, Jane Harmer, Leah M C McGee, Daniel P Brooke

ACS Infect Dis· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Truncated S-MGBs: towards a parasite-specific and low aggregation chemotype.
Daniel P Brooke, Leah M C McGee, Federica Giordani, Jasmine M Cross, Abedawn I Khalaf

RSC Med Chem· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Truncated S-MGBs: towards a parasite-specific and low aggregation chemotype.
Daniel P Brooke, Leah M C McGee, Federica Giordani, Jasmine M Cross, Abedawn I Khalaf

RSC Med Chem· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plasma glial fibrillary acidic protein and neurofilament light chain, but not tau, are biomarkers of sports-related mild traumatic brain injury.
Etienne Laverse, Tong Guo, Karl Zimmerman, Martha S Foiani, Bharat Velani, Daniel Brooke

Brain Commun· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II trial of eribulin in patients who do not achieve pathologic complete response (pCR) following neoadjuvant chemotherapy.
Denise A Yardley, Nancy Peacock, Brooke Daniel, Betrand Anz, David C Molthrop

Breast Cancer Res Treat· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TITAN: phase III study of doxorubicin/cyclophosphamide followed by ixabepilone or paclitaxel in early-stage triple-negative breast cancer.
Denise A Yardley, Edward R Arrowsmith, Brooke R Daniel, Janice Eakle, Adam Brufsky

Breast Cancer Res Treat· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Ramucirumab With Eribulin Versus Eribulin in Locally Recurrent or Metastatic Breast Cancer Previously Treated With Anthracycline and Taxane Therapy: A Multicenter, Randomized, Phase II Study.
Denise A Yardley, James Reeves, E Claire Dees, Cynthia Osborne, Devchand Paul, Brooke Daniel

Clin Breast Cancer· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of a multiplexed immunoassay (PRO Onc assay) to detect HER2 abnormalities in circulating tumor cells of women with HER2-negative metastatic breast cancer: lack of response to HER2-targeted therapy.
John D Hainsworth, Patrick B Murphy, Jose R Alemar, Brooke R Daniel, Robyn R Young

Breast Cancer Res Treat· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Panitumumab, Gemcitabine, and Carboplatin as Treatment for Women With Metastatic Triple-Negative Breast Cancer: A Sarah Cannon Research Institute Phase II Trial.
Denise A Yardley, Patrick J Ward, Brooke R Daniel, Janice F Eakle, Ruth E Lamar

Clin Breast Cancer· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neoadjuvant Ixabepilone/Carboplatin/Trastuzumab in HER2-Positive Operable Breast Cancer: A Phase II Trial of the Sarah Cannon Research Institute.
Denise A Yardley, John D Zubkus, Janice F Eakle, Rebecca G Bechhold, Lindsey Finney, Davey Daniel, Brooke Daniel

Clin Breast Cancer· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Addition of bevacizumab to three docetaxel regimens as adjuvant therapy for early stage breast cancer.
Denise A Yardley, Lowell Hart, David Waterhouse, Robert Whorf, D Randolph Drosick, Brooke R Daniel

Breast Cancer Res Treat· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The design and use of a simple System Suitability Test Mix for generic reverse phase high performance liquid chromatography-mass spectrometry systems and the implications for automated system monitoring using global software tracking.
Ian Mutton, Bob Boughtflower, Nick Taylor, Daniel Brooke

J Chromatogr A· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase II trial of dose-dense neoadjuvant gemcitabine, epirubicin, and albumin-bound paclitaxel with pegfilgrastim in the treatment of patients with locally advanced breast cancer.
Denise A Yardley, John Zubkus, Brooke Daniel, Roger Inhorn, Cassie M Lane

Clin Breast Cancer· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Parallel preparative high-performance liquid chromatography with on-line molecular mass characterization.
Christine Edwards, Jianbo Liu, Thomas J Smith, Daniel Brooke, David J Hunter

Rapid Commun Mass Spectrom· November 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis